Since the 18th National Congress of the Communist Party of China, the development of traditional Chinese medicine has gradually risen to a national strategy. In the fight against the new crown pneumonia epidemic, traditional Chinese medicine is deeply involved in the whole process of diagnosis and treatment, and has played an important role in enhancing immunity and reducing the infection rate and mortality rate.

In order to actively respond to the national "One Belt, One Road" internationalization strategy and let traditional Chinese medicine go to the world, Mengyang Pharmaceutical officially launched the internationalization process of the company's products in 2017. As an important part of the international development of the company, the company's main Chinese patent medicine "Shengbai Oral Liquid" is based on the clinical efficacy and the characteristics of available quantitative index evaluation that have been proven for many years, combined with the favorable environment of Canadian natural medicine policies and regulations, with Beijing Mengyang Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary registered in Zhongguancun Yizhuang Biomedical Industrial Park, as the international licensee, and "Hubei Mengyang Pharmaceutical Co., Ltd." as the international manufacturer, to carry out the registration of the flagship product "Shengbai Oral Liquid" in Canada. The project has also been included in the major project of the Ministry of Science and Technology for the modernization of traditional Chinese medicine: demonstration research on international cooperation in traditional Chinese medicine for the "Belt and Road" countries.

Today, the successful approval of the registration of natural medicines by the Natural and OTC Drug Administration of Health Canada marks a major progress in the internationalization of Mengyang Pharmaceutical, and Shengbai Oral Liquid will have the opportunity to enter the Canadian market in the name of drugs (non-health food), fully make up for the defects and deficiencies of similar products with unique clinical characteristics and advantages, provide more adequate and effective treatment options for the majority of patients, and play a positive role in demonstrating and promoting the internationalization of traditional Chinese medicine.